BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0

Historical Portfolio Holders from Q3 2017 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 0.599% 8/0
Principal, excl. options Q1 2024
414 M
Holdings value Q1 2024
$409 M
Value change Q1 2024
+$16.5 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
55
Number of buys Q1 2024
0
Number of sells Q1 2024
-1
Average buys Q1 2024 %
0
Average sells Q1 2024 %
0%
CUSIP
09061GAH4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q2 $6.09 M $5.97 M -$2.14 M $0.98 1
2024 Q1 $414 M $409 M +$16.5 M $0.98 55
2023 Q4 $397 M $394 M +$29.4 M $0.99 61
2023 Q3 $364 M $360 M -$17.4 M $0.97 61
2023 Q2 $386 M $382 M -$19.2 M $0.98 56
2023 Q1 $400 M $416 M +$41.9 M $1.03 56
2022 Q4 $365 M $391 M +$39.8 M $1.06 54
2022 Q3 $317 M $316 M -$56.6 M $0.99 47
2022 Q2 $362 M $347 M -$5.81 M $0.99 48
2022 Q1 $372 M $372 M +$24.1 M $1.00 47
2021 Q4 $343 M $361 M -$45.2 M $1.05 45
2021 Q3 $387 M $399 M -$3.32 M $1.03 45
2021 Q2 $390 M $407 M -$70.4 M $1.04 41
2021 Q1 $463 M $474 M +$19.4 M $1.02 46
2020 Q4 $444 M $477 M +$11.3 M $1.07 49
2020 Q3 $430 M $456 M +$5.75 M $1.05 48
2020 Q2 $423 M $523 M +$5.04 M $1.22 53
2020 Q1 $422 M $442 M +$54.4 M $1.05 48
2019 Q4 $370 M $392 M -$115 M $1.06 49
2019 Q3 $483 M $480 M -$7.01 M $0.99 42
2019 Q2 $490 M $511 M +$24.3 M $1.04 44
2019 Q1 $470 M $480 M -$22 M $1.02 46
2018 Q4 $492 M $490 M +$15.2 M $0.99 42
2018 Q3 $474 M $506 M +$63.2 M $1.07 43
2018 Q2 $393 M $901 M +$22.1 M $1.01 37
2018 Q1 $396 M $840 M +$442 M $0.94 39
2017 Q4 $404 M $405 M +$1.87 M $1.00 46
2017 Q3 $401 M $408 M +$408 M $1.02 40